Search Within

Anne Covey

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (8)
Groups
  1. Interventional Radiology Service (23)
  2. Population Sciences Research Program (23)
  3. Radiology, Department of (23)
  4. Center for Pancreatic Cancer Research (18)
  5. Biostatistics Service (16)
  6. Epidemiology and Biostatistics (16)

More Groups

People
  1. Lynn Brody (14)
  2. Michael D'Angelica (12)
  3. T Peter Kingham (12)
  4. Hooman Yarmohammadi (11)
  5. Karen Brown (10)
  6. William Jarnagin (10)

More People

Years
  1. 2024 (5)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (4)
  6. 2017 (1)

More Years

Publications
  1. Journal of Vascular and Interventional Radiology (4)
  2. Cancer Research (2)
  3. Cancers (2)
  4. HPB (2)
  5. JAMA Surgery (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (6)
  2. Elsevier Inc. (3)
  3. American Association for Cancer Research (2)
  4. American Medical Association (2)
  5. American Society of Clinical Oncology (2)
  6. MDPI (2)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes
    Meeting Abstract

    Vasiniotis Kamarinos, N.; Vakiani, E.; Gonen, M.; Kemeny, N. E.; Covey, A. M.; Brown, K. T.; Brody, L. A.; Deipolyi, A. R.; Camacho, J.; Boas, F. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Quality of life improves after palliative placement of percutaneous tunneled drainage catheter for refractory ascites in prospective study of patients with end-stage cancer
    Journal Article

    Robson, P.; Gonen, M.; Ni, A.; Brody, L.; Brown, K. T.; Getrajdman, G.; Thom, B.; Kline, N.; Covey, A.
    Palliative and Supportive Care (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of hepatic artery embolization in treating solitary fibrous tumor metastatic to the liver
    Journal Article

    Velayati, S.; Erinjeri, J. P.; Brody, L. A.; Ziv, E.; Boas, F. E.; Brown, K. T.; Covey, A. M.; Getrajdman, G. I.; Solomon, S. B.; Kingham, P. T.; more...
    Sarcoma (2019)

    Fulltext@MSK | Save
  • Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection
    Journal Article

    Al Efishat, M.; Attiyeh, M. A.; Eaton, A. A.; Gönen, M.; Covey, A. M.; D'Angelica, M. I.; DeMatteo, R. P.; Kingham, T. P.; Balachandran, V.; Jarnagin, W. R.; more...
    HPB (2019)

    Fulltext@MSK | Save
  • Autologous blood patch injection versus hydrogel plug in CT-guided lung biopsy: A prospective randomized trial
    Journal Article

    Maybody, M.; Muallem, N.; Brown, K. T.; Moskowitz, C. S.; Hsu, M.; Zenobi, C. L.; Jihad, M.; Getrajdman, G. I.; Sofocleous, C. T.; Erinjeri, J. P.; more...
    Radiology (2019)

    Fulltext@MSK | Save
  • Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature
    Journal Article

    Maybody, M.; Madoff, D. C.; Thornton, R. H.; Morales, S. A.; Moskowitz, C. S.; Hsu, M.; Brody, L. A.; Brown, K. T.; Covey, A. M.
    Clinical Imaging (2017)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save